Related content

NCCN Clinical Practice Guidelines in Oncology: Multiple Myeloma

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 9, 2009-10 ,pp. : 908-908

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

From cell biology to therapy: ENMD-2076 in the treatment of multiple myeloma

By Zhang Shuhong   Farag Sherif S  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 7, 2011-07 ,pp. : 1015-1028

Informa Healthcare

Access to resources Recommend Favorite

Multiple myeloma

By Samson Diana   Singer Charles  

Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. : 365-370

Royal College Of Physicians

Access to resources Recommend Favorite

Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment

By  

Current Cancer Drug Targets, Vol. 17, Iss. 9, 2017-10 ,pp. : 819-838

Bentham Science Publishers

Access to resources Recommend Favorite

Thalidomide in multiple myeloma – clinical trials and aspects of drug metabolism and toxicity

By Breitkreutz Iris   Anderson Kenneth C  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 973-985

Informa Healthcare

Access to resources Recommend Favorite